Health~Holland
Eureka Biotech Call 2026
Central EUREKA submission + national documentation required; Dutch consortia encouraged to notify RVO and Health Holland in advance
Last verified:
The Eureka Biotech Call 2026 funds Dutch SMEs and research organisations in international consortia developing cell and gene therapies (CGT) and organ-on-chip (OoC) technologies at technology readiness levels 4-7. Each Dutch partner receives €400,000-€750,000, with consortia requiring at least two Dutch partners (one company, one research organisation) plus at least two partners from priority countries (Belgium, France, Germany, Singapore, Spain, Sweden, Switzerland). This is a one-off call supporting translation of promising biotech innovations through public-private partnership.
Details
| Funder | Health~Holland |
| Budget | €400k–€750k per project (Dutch partners) |
| Deadline | 25 September 2026 |
| Consortium | Required — at least 2 Dutch partners (1 company + 1 research organisation) and at least 2 partners from a priority country (1 company + 1 research organisation); priority countries: Belgium, France, Germany, Singapore, Spain, Sweden, Switzerland |
| Application | 2-stage: central EUREKA submission portal, then national submission portal |
| TRL | 4-7 |
| Frequency | One-off |
| Eligible countries | NL |
Eligibility & scope
PPP subsidy for Dutch SMEs and research organisations participating in international R&D consortia focused on cell and gene therapies (CGT) and Organ-on-Chip (OoC) technologies (TRL 4–7). Healthcare providers and foundations are not eligible. International partners must secure their own funding. Co-funding (in-kind and/or cash) by all partners is required.
Who Should Apply
- •Dutch SMEs and research organisations (not healthcare providers or foundations)
- •Partners in international consortia with at least one company and one research organisation from priority countries
- •Projects in cell and gene therapy or organ-on-chip technologies at TRL 4-7
- •Consortia with commitment to co-funding (cash and/or in-kind contributions from all partners)
Key Dates
- •Deadline: 25 September 2026 (central EUREKA submission portal, followed by national documentation submission)
- •Two-stage application: central portal submission, then national submission via RVO/Health Holland
- •Pre-notification encouraged: consortia should notify RVO and Health Holland in advance of submission
Tips for Applicants
- ✓Consortium composition is gating: ensure you have confirmed letters of commitment from at least two international priority-country partners (one company, one research organisation) before submitting; mismatched consortia are rejected at triage.
- ✓International partners must independently secure their own funding; your Dutch subsidy application will not accelerate their approval. Clarify this early with all consortium members.
- ✓Co-funding is mandatory for all partners. Document in-kind contributions (staff time, equipment use) and cash co-funding commitments explicitly in the submission; vague co-funding pledges risk scoring penalties in review.
Frequently Asked Questions
How much does the Eureka Biotech Call 2026 pay Dutch partners?
Each Dutch partner receives €400,000-€750,000, with the exact amount depending on project scope and host institution. International partners must secure separate funding.
What technologies does the Eureka Biotech Call 2026 fund?
Cell and gene therapies (CGT) and organ-on-chip (OoC) technologies at technology readiness levels 4-7.
Who must be in a consortium for the Eureka Biotech Call 2026?
At least two Dutch partners (one company, one research organisation) and at least two partners from priority countries, Belgium, France, Germany, Singapore, Spain, Sweden, or Switzerland (one company, one research organisation from each priority country).
Are healthcare providers eligible for the Eureka Biotech Call 2026?
No, healthcare providers and foundations are not eligible. Only Dutch SMEs and research organisations can apply.
Is the Eureka Biotech Call 2026 a one-time call?
Yes, this is a one-off call with a deadline of 25 September 2026; there is no annual recurrence announced.
Summary generated by AI based on published grant information. Always verify details on the funder's website.
More from Health~Holland
Science for Industry Call
Deadline: 22 Sept 2026€500k–€1.2M PPP subsidy per project (large enterprises: personnel costs only, up to €250k)Health~Holland Science for Industry Call 2026
Deadline: 22 Sept 2026€500,000-€1,200,000 PPPHealth~Holland Organ-on-Chip Call 2026
Deadline: 22 Sept 2026PPP subsidyEureka Biotech Call
Deadline: 25 Sept 2026€400k–€750k PPP subsidy per project (Dutch partners)SME Call 2027
Deadline: 30 Nov 2026
Browse Related
Could Eureka Biotech Call 2026 be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →